{
  "58c8ea03": {
    "title": "Parkinson Disease",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Movement Disorder",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Parkinson Disease"
    ],
    "content": {
      "definition": "<p><b>Parkinson Disease</b> is a progressive <i>neurodegenerative movement disorder</i> caused by the <u>selective loss</u> of [[63593303|dopaminergic neurons]] in the substantia nigra pars compacta (SNc), characterized by the accumulation of intracellular eosinophilic inclusions known as <b>Lewy bodies</b> (composed of $\\alpha$-synuclein).</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Depletion of dopamine in the [[c30e26a4|nigrostriatal pathway]] leads to disinhibition of the indirect pathway and inhibition of the direct pathway within the [[ed462927|basal ganglia]], resulting in net motor inhibition.</li><li><b>Clinical Presentation:</b> The classic <b>TRAP</b> tetrad: <b>T</b>remor (pill-rolling at rest), <b>R</b>igidity (cogwheel), <b>A</b>kinesia/bradykinesia (shuffling gait, masked facies), and <b>P</b>ostural instability.</li><li><b>Histology:</b> Loss of pigmented neurons in the SNc and presence of <b>Lewy bodies</b>.</li><li><b>Treatment:</b> Increase dopamine availability (e.g., [[335b4671|Levodopa/carbidopa]]), inhibit breakdown (e.g., [[227f8980|Selegiline]]), or stimulate receptors directly (e.g., [[c36650bd|dopamine agonists]]).</li><li><b>USMLE Tip:</b> Differentiate from [[db2f16e5|Lewy body dementia]] by the timeline: in PD, motor symptoms precede cognitive decline by >1 year; in LBD, dementia occurs within 1 year of motor onset.</li></ul>",
      "takeAway": "<p>The fundamental deficit in <b>Parkinson Disease</b> is the loss of dopaminergic input to the [[644fc3b4|striatum]], which normally facilitates movement via D1 receptors (direct pathway) and suppresses inhibition via D2 receptors (indirect pathway); the resulting imbalance creates a hypokinetic or \"frozen\" motor state.</p>",
      "mermaid": "graph TD; SNc_Loss-->Decreased_Dopamine; Decreased_Dopamine-->Inhibit_Direct_Pathway; Decreased_Dopamine-->Disinhibit_Indirect_Pathway; Inhibit_Direct_Pathway-->Decreased_Movement; Disinhibit_Indirect_Pathway-->Decreased_Movement;"
    },
    "connections": [
      {
        "type": "is_caused_by_loss_of",
        "to": "63593303"
      },
      {
        "type": "is_treated_by",
        "to": "335b4671"
      },
      {
        "type": "is_treated_by",
        "to": "c36650bd"
      },
      {
        "type": "accumulates",
        "to": "db2f16e5"
      },
      {
        "type": "involves_dysfunction_of",
        "to": "ed462927"
      }
    ]
  },
  "63593303": {
    "title": "Substantia Nigra pars compacta (SNc)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Basal Ganglia"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Substantia Nigra pars compacta"
    ],
    "content": {
      "definition": "<p>The <b>Substantia Nigra pars compacta (SNc)</b> is a specific population of <i>pigmented, dopaminergic neurons</i> located in the midbrain tegmentum that serves as the primary source of [[90adc821|dopamine]] for the [[3fa071ef|caudate]] and putamen (striatum), modulating the direct and indirect pathways of the [[ed462927|basal ganglia]].</p>",
      "atAGlance": "<ul><li><b>Function:</b> Synthesizes dopamine from tyrosine to modulate voluntary movement intensity and coordination via the [[c30e26a4|nigrostriatal pathway]].</li><li><b>Location:</b> Midbrain, appearing as a dark band (\"substantia nigra\" = black substance) due to <b>neuromelanin</b> accumulation as a byproduct of dopamine synthesis.</li><li><b>Pathology:</b> Selective degeneration occurs in [[58c8ea03|Parkinson disease]].</li><li><b>USMLE Tip:</b> Gross examination of a brain with advanced Parkinson's reveals distinct <mark>depigmentation</mark> (pallor) of the substantia nigra compared to a healthy brain.</li></ul>",
      "takeAway": "<p>The <b>SNc</b> acts as the \"volume dial\" for movement; without its dopaminergic output, the basal ganglia defaults to a state of excessive inhibition of the [[afc0a64b|thalamus]], preventing motor initiation.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "degenerates_in",
        "to": "58c8ea03"
      },
      {
        "type": "projects_to",
        "to": "644fc3b4"
      },
      {
        "type": "is_part_of",
        "to": "ed462927"
      },
      {
        "type": "produces",
        "to": "90adc821"
      }
    ]
  },
  "45dd6d19": {
    "title": "Multiple Sclerosis",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Demyelinating"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Multiple Sclerosis"
    ],
    "content": {
      "definition": "<p><b>Multiple Sclerosis</b> is an autoimmune <i>inflammatory demyelinating disease</i> of the central nervous system mediated by autoreactive T-cells and macrophages targeting [[a24f9747|oligodendrocytes]], resulting in multiple white matter lesions separated by <u>space</u> (anatomy) and <u>time</u>.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Th1 and Th17 cells cross the [[dd47b9cc|blood-brain barrier]], recognize myelin antigens, and recruit macrophages, leading to plaque formation and axonal transection.</li><li><b>Clinical Presentation:</b> Relapsing-remitting symptoms including [[98a63a59|optic neuritis]] (painful visual loss), [[58c684bd|internuclear ophthalmoplegia]] (INO), scanning speech, intention tremor, and bladder dysfunction.</li><li><b>Diagnosis:</b> MRI showing [[d9286430|periventricular plaques]] (Dawson fingers); CSF showing <b>oligoclonal bands</b> (IgG) and elevated myelin basic protein.</li><li><b>Treatment:</b> Acute flares managed with IV [[adc34ee4|steroids]]; disease-modifying therapies include [[00e48ea3|$\\beta$-interferon]], [[88fffc48|glatiramer]], and [[ae20a0ce|natalizumab]].</li><li><b>USMLE Tip:</b> The combination of a young female patient with visual changes and an MLF lesion (bilateral INO) is <mark>pathognomonic</mark> for MS; unilateral INO is often vascular (stroke).</li></ul>",
      "takeAway": "<p><b>Multiple Sclerosis</b> is defined by the spatial and temporal dissemination of lesions; identifying two distinct neurological deficits occurring at different times (e.g., optic neuritis followed by paresthesias months later) is key to the clinical diagnosis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "causes",
        "to": "58c684bd"
      },
      {
        "type": "causes",
        "to": "98a63a59"
      },
      {
        "type": "damages",
        "to": "a24f9747"
      },
      {
        "type": "is_treated_by",
        "to": "00e48ea3"
      },
      {
        "type": "presents_with",
        "to": "d9286430"
      }
    ]
  },
  "58c684bd": {
    "title": "Internuclear Ophthalmoplegia (INO)",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Internuclear Ophthalmoplegia"
    ],
    "content": {
      "definition": "<p><b>Internuclear Ophthalmoplegia (INO)</b> is a specific <i>conjugate horizontal gaze palsy</i> caused by a lesion in the [[59ad6172|medial longitudinal fasciculus]] (MLF), characterized by <u>impaired adduction</u> of the ipsilateral eye and <b>nystagmus</b> of the contralateral abducting eye during lateral gaze.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Disruption of the highly myelinated pathway connecting the [[01c1b782|CN VI]] nucleus (pons) to the contralateral [[68c66997|CN III]] nucleus (midbrain).</li><li><b>Clinical Sign:</b> When looking LEFT, the RIGHT eye cannot adduct (stuck at midline), and the LEFT eye exhibits nystagmus. Convergence is typically preserved.</li><li><b>Etiology:</b> Bilateral lesions are classic for [[45dd6d19|Multiple sclerosis]] in young patients; unilateral lesions suggest lacunar stroke in elderly patients.</li><li><b>USMLE Tip:</b> Remember the mnemonic \"INO = <b>I</b>psilateral adduction failure, <b>N</b>ystagmus <b>O</b>pposite.\" The side of the INO is the side of the adduction deficit (MLF lesion side).</li></ul>",
      "takeAway": "<p>The hallmark of <b>INO</b> is the dissociation between horizontal gaze (impaired adduction) and convergence (preserved adduction), proving the lesion is in the interconnecting tract (MLF) rather than the medial rectus muscle or oculomotor nerve itself.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_caused_by_lesion_in",
        "to": "59ad6172"
      },
      {
        "type": "is_a_sign_of",
        "to": "45dd6d19"
      },
      {
        "type": "involves_dysfunction_of",
        "to": "68c66997"
      },
      {
        "type": "involves_dysfunction_of",
        "to": "01c1b782"
      }
    ]
  },
  "59ad6172": {
    "title": "Medial Longitudinal Fasciculus (MLF)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Ophthalmology"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Medial Longitudinal Fasciculus"
    ],
    "content": {
      "definition": "<p>The <b>Medial Longitudinal Fasciculus (MLF)</b> is a heavily myelinated <i>white matter tract</i> located near the midline of the brainstem that integrates inputs from the oculomotor, trochlear, abducens, and vestibular nuclei to coordinate <b>conjugate eye movements</b> and vestibulo-ocular reflexes.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Transmits excitatory signals from the [[01c1b782|abducens nucleus]] (CN VI) to the contralateral [[68c66997|oculomotor nucleus]] (CN III) medial rectus subnucleus to allow coordinated horizontal gaze.</li><li><b>Location:</b> Dorsal pons and midbrain, ventral to the fourth ventricle/cerebral aqueduct.</li><li><b>Vulnerability:</b> Highly susceptible to demyelination in [[45dd6d19|Multiple sclerosis]] due to high myelin content required for rapid signal transmission.</li><li><b>USMLE Tip:</b> Think of the MLF as the \"sync cable\" that allows you to look to the side with <i>both</i> eyes simultaneously.</li></ul>",
      "takeAway": "<p>Speed is essential for binocular vision to prevent diplopia during rapid eye movements; the <b>MLF's</b> heavy myelination facilitates this speed but makes it a prime target in demyelinating diseases like MS, leading to [[58c684bd|INO]].</p>",
      "mermaid": "graph LR; CN_VI_Nucleus-->MLF; MLF-->Contralateral_CN_III; Contralateral_CN_III-->Medial_Rectus;"
    },
    "connections": [
      {
        "type": "connects",
        "to": "01c1b782"
      },
      {
        "type": "connects",
        "to": "68c66997"
      },
      {
        "type": "lesion_causes",
        "to": "58c684bd"
      },
      {
        "type": "is_damaged_in",
        "to": "45dd6d19"
      }
    ]
  },
  "3ce6c035": {
    "title": "Glaucoma",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Glaucoma"
    ],
    "content": {
      "definition": "<p><b>Glaucoma</b> is a group of <i>optic neuropathies</i> characterized by progressive structural damage to the [[0fee2f38|optic nerve]] and retinal ganglion cells, usually (but not always) associated with elevated <b>intraocular pressure (IOP)</b>, leading to peripheral vision loss.</p>",
      "atAGlance": "<ul><li><b>Types:</b> <b>Open-angle</b> (painless, gradual, trabecular meshwork dysfunction) vs. <b>Closed-angle</b> (painful, acute emergency, pupillary block).</li><li><b>Pathophysiology:</b> Imbalance between [[d595b0bf|aqueous humor]] production (ciliary body) and outflow (trabecular meshwork/uveoscleral pathway).</li><li><b>Fundoscopy:</b> Pathologic <mark>cupping</mark> of the optic disc (cup-to-disc ratio > 0.5).</li><li><b>Treatment:</b> Decrease production ([[10535992|$\\beta$-blockers]], [[bc6647e5|$\\alpha$-agonists]], [[1df262e8|carbonic anhydrase inhibitors]]) or increase outflow ([[73ad9529|prostaglandins]], [[36054a34|cholinomimetics]]).</li><li><b>USMLE Tip:</b> Acute Angle-Closure Glaucoma presents as a painful red eye, rock-hard to palpation, with a fixed mid-dilated pupilâ€”<u>do not give epinephrine</u> (mydriasis worsens the angle).</li></ul>",
      "takeAway": "<p>Vision loss in <b>Glaucoma</b> is typically peripheral (\"tunnel vision\") and irreversible because the increased pressure compresses the optic nerve vasculature and axons at the lamina cribrosa, inducing apoptosis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_treated_by",
        "to": "1df262e8"
      },
      {
        "type": "is_treated_by",
        "to": "73ad9529"
      },
      {
        "type": "is_treated_by",
        "to": "10535992"
      },
      {
        "type": "damages",
        "to": "66b11030"
      },
      {
        "type": "is_associated_with",
        "to": "6b5db87a"
      }
    ]
  }
}